NCT07177157View on ClinicalTrials.gov

The Prospective Improved Vitamin D Study for Inflammatory Bowel Disease Patients

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Ulcerative Colitis (UC)IBD (Inflammatory Bowel Disease)Crohn Disease (CD)
Interventions
DIETARY_SUPPLEMENT

Vitamin D3 (Cholecalciferol)

2000 IU of Vitamin D daily (1 pill)

Trial Locations (1)

N6A 5A5

Victoria Hospital - London Health Sciences Centre, London

All Listed Sponsors
lead

Terry Ponich

OTHER

NCT07177157 - The Prospective Improved Vitamin D Study for Inflammatory Bowel Disease Patients | Biotech Hunter | Biotech Hunter